https://www.selleckchem.com/pr....oducts/bobcat339.htm
However, patients in the CI group had a significantly longer sedation induction time (5.28 minutes vs. 4.34 minutes, p less then 0.01) and received a higher dose of propofol than patients in the BI group (4.22 mg/kg vs. 2.08 mg/kg, p less then 0.01). There was no significant difference in adverse events between the two groups. Conclusions Continuous infusion of propofol during therapeutic ERCP had the advantage over intermittent bolus injection of maintaining a constant level of sedation without increasing adverse events. However, it
Like
Comment
Share
